Press Releases

 Filter by Provider

Newegg Commerce, Inc. (NASDAQ: NEGG) (the “Company”), a global leader in e-commerce for computer and technology products, today announced the grand opening of the Newegg Gamer Zone, a 2,300-square-foot, cutting-edge gaming arena located at Newegg’s headquarters in Diamond Bar, California.

Charles River Laboratories International, Inc. (NYSE: CRL) has joined the EASYGEN (Easy Workflow Integration for Gene Therapy) Consortium, a European Union (EU)-backed effort to produce CAR-T cell therapies faster, make them more affordable, and increase patient access throughout Europe. The Consortium aims to develop a fully automated, hospital-based platform capable of manufacturing personalized cell therapies within 24 hours.

Nomi Health today announced a strategic partnership with Hillcrest HealthCare System that will redefine how Tulsa-area citizens access healthcare through innovative employer benefits. Through this partnership, employers will lower their healthcare costs while giving employees access to comprehensive medical care across Hillcrest’s extensive network—including eight hospitals, more than 80 care sites, and 6,400+ team members—with zero out-of-pocket costs.

Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the expiration and final tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase for cash any and all of the Issuer’s outstanding 5.625% Senior Secured Notes due 2027 (the “Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2025, as amended (the “Offer to Purchase”). As previously announced, as of 5:00 p.m., New York City time, on August 8, 2025 (the “Early Tender Deadline”), $1,735,362,000 aggregate principal amount, or approximately 98.77%, of the Notes were validly tendered and not validly withdrawn, for which payment was previously made on August 12, 2025. According to Global Bondholder Services Corporation, the depositary and information agent for the Tender Offer, subsequent to the Early Tender Deadline but at or prior to 5:00 p.m., New York City time, on August 25, 2025 (the “Expiration Time”), an additional $7,889,000 aggregate principal amount of the outstanding Notes were validly tendered and not validly withdrawn. All of the Notes validly tendered and not validly withdrawn by the Expiration Time were accepted for purchase by the Issuer.

Instant Financial (Instant), a leader in earned wage access (EWA) and digital tipping solutions, and Payouts Network, the modern B2C payments platform that transforms consumer experiences, today announced a new capability that lets employees move earned wages to their existing bank accounts in real-time. The update, delivered through Instant Pay, Instant’s EWA solution and enabled by Payouts Network’s real-time payouts technology, gives workers more choice and helps employers deliver a better pay experience.

Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced that the first patient has been dosed in the company’s Phase II Nightingale clinical trial evaluating QLS‑111, the company’s lead investigational therapy, in patients with normal tension glaucoma (NTG). The Nightingale study is Qlaris Bio’s third Phase II clinical trial of QLS‑111 and will seek to build upon the positive clinical data generated in the previous Phase II Osprey and Apteryx clinical trials. Notably, the Nightingale study will be conducted in South Korea, which provides access to a large NTG patient population due to its high prevalence in Asia.

Vasion, a leader in serverless printing and AI-enabled automation, announced today it has achieved a significant milestone by being listed as “In Process” on the FedRAMP Marketplace. This listing is a final step in the authorization process for the Federal Risk and Authorization Management Program (FedRAMP), which provides the gold standard for cloud security in the government sector.

Aurascape today announced that its research team, Aura Labs, discovered and responsibly disclosed a vulnerability in OpenAI’s ChatGPT Agent Mode. OpenAI has since patched the issue, reinforcing enterprise trust in adopting emerging AI features.

Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-directed, TOPO1-inhibitor antibody-drug conjugate (ADC), for the treatment of adult patients with recurrent or progressive endometrial cancer (EC) who have disease progression on or following prior treatment with a platinum-containing regimen and a PD-(L)1 therapy. BTD aims to expedite the development and review of investigational medicines by the U.S. FDA for serious or life-threatening diseases in cases where preliminary clinical evidence shows that a therapy may provide substantial improvements over available therapies.

PulteGroup, Inc. (NYSE: PHM) today announced that it will release its third quarter 2025 financial results before the market opens on Tuesday, October 21, 2025. The Company will hold a conference call to discuss its third quarter results that same day at 8:30 a.m. (ET).

The gap between 10-year treasury yields and mortgage rates (known as the mortgage spread) has dropped to its lowest level in over three years, allowing mortgage rates to fall more than treasury yields. That’s according to a new report from Redfin, the real estate brokerage powered by Rocket.

AI Proteins, a biotech company pioneering a new class of de novo therapeutic miniproteins designed by artificial intelligence, today announced the appointment of Dr. James Bowman, PhD as its first Chief Technology Officer. In this role, James will drive the expansion of the company’s core technology platform, integrating machine learning, synthetic biology, robotics, and large-scale data analysis to create entirely novel protein therapeutics. He previously served as AI Proteins’ Director of Protein Engineering, where he helped establish the framework that powers the company’s discovery engine.

Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced that initial pharmacokinetics, dosimetry and safety data from the company’s ongoing first-in-human Phase 1 dose-escalation trial of ABD-147, a novel DLL3-targeting radiopharmaceutical, will be presented at the IASLC 2025 World Conference on Lung Cancer (WCLC), being held September 6-9 in Barcelona, Spain.

Magic Science Corporation, the health sciences company behind the fast-growing skincare brand Magic Molecule, today announced an investment by NexPhase Capital (“NexPhase” or “NPC”), a thematically driven and operationally-focused private equity firm. The investment will fuel Magic Science Corporation’s expansion across product, retail distribution, and category-defining, science-backed skincare and household consumer goods.

Nearly nine in 10 business leaders now say their contact centers, traditionally utilized solely as service endpoints, have become core to their strategic innovation, a new industry study has found. Published by Glia, the leader in AI-powered interactions for banking, the survey signals a pivotal elevation in the contact center’s value as AI unlocks the wealth of untapped intelligence contained in customer and member interactions for banks and credit unions.

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the dosing of the first healthy volunteer in its randomized, double-blind, placebo-controlled, Phase I trial Debio 1453-101 (NCT07035769) ‘A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults’. Debiopharm's Debio 1453 aims to enhance the current range of treatment options by offering a novel antibiotic with an entirely new mechanism of action against Neisseria gonorrhoeae (N. gonorrhoeae) infections.

National affordable housing innovator Arrive Home is pleased to announce that it now serves six of the nation’s top 10 mortgage lenders as it celebrates record growth upon its third-year anniversary.

Drive Health, a leader in agentic healthcare labor solutions, today announced a strategic contract with Banyan Medical Solutions, the nation’s foremost provider of virtual nursing services. Together, the two companies will deploy an integrated AI co-pilot solution designed to alleviate the impact of the U.S. healthcare staffing crisis by augmenting human care teams in acute care settings across the country.

Perfect Corp., the leading AI and AR beauty and fashion tech solutions provider, is excited to announce its highly anticipated Global Beauty & Fashion AI Forum, taking place on Tuesday, September 16th, 2025, during New York Fashion Week at the Metropolitan Pavilion, located at 125 West 18th Street, New York City. This must-attend event will bring together thought leaders and visionary brands to explore how AI is revolutionizing the customer experience and delivering hyper-personalized shopping journeys across the beauty and fashion industries. In addition to an exciting day of panel discussions, AI/AR technology showcases, and networking with top industry leaders, this year’s Forum will feature an AI-powered interactive fashion presentation in partnership with Nolcha Shows during NYFW. Attendees will have the opportunity to virtually try on featured runway looks with Perfect Corp.’s precise Generative AI technology, bringing the cutting-edge creativity of the designers to life in a fully immersive experience.

With an influx of Californians expected to travel over Labor Day weekend, agricultural officials are cautioning Californians on what NOT to pack for their trips – homegrown citrus fruit and plant material.

Carvana (NYSE: CVNA), an industry pioneer for buying and selling used cars online, today announced plans to bring Inspection and Reconditioning Center (IRC) capabilities to its existing ADESA Dallas wholesale auction site. The integration expands Carvana’s national reconditioning network, creates a new pool of retail inventory in the Dallas–Fort Worth area, and strengthens the company’s offerings for both retail and wholesale customers in the region.

Eagle Crusher Co., Inc. is proud to announce West Side Tractor as its new distributor for the state of Iowa, representing the full line of Eagle Crusher heavy-duty crushing and screening equipment for the recycled concrete, asphalt, aggregate, and sand and gravel industries.

Luxury Presence, the leading AI marketing platform for real estate agents, today announced it has surpassed $75M in annual recurring revenue (ARR), expanded its investment in AI product and engineering teams by 300% since January 2025, and added high-profile leaders including Kyle Scott, former president of SERHANT. Ventures and former NBC News producer.

Affirm Holdings, Inc. (NASDAQ: AFRM) (“Affirm” or the “Company”), the payment network that empowers consumers and helps merchants drive growth, today announced that the Company will participate in the following investor conferences:

The "Global Quantum Sensors Market 2026-2046" report has been added to ResearchAndMarkets.com's offering.

As National Preparedness Month arrives this September, T-Mobile (NASDAQ: TMUS) has expanded technology and resources to support connectivity when communities face natural disasters and severe storms — expanding its drone fleet, launching T-Satellite with Starlink, adding more deployable assets and vehicles and further hardening the network. Together, these investments mean people can better stay in touch with loved ones, receive critical alerts and access essential services. For first responders, the expansions support reliable communications and faster coordination in the field. Ahead of National Preparedness Month, here’s what’s new:

o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced its membership in the Catena-X community. This development builds upon o9's achievement of the Catena-X Demand and Capacity Management (DCM) certification in October 2024, marking a significant step in its commitment to fostering standardized, secure, and collaborative data exchange within the automotive industry.

The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program.

Brown-Forman Corporation (NYSE: BFA, BFB) announced today that President and Chief Executive Officer Lawson Whiting and Executive Vice President and Chief Financial Officer Leanne Cunningham will participate in a “fireside chat” during the Barclays Global Consumer Staples Conference in Boston on Wednesday, September 3, 2025. The event will begin at approximately 12:45 p.m. (EDT) and will be available as a webcast on the Brown-Forman website at brown-forman.com on the Investors/Events & Presentations page. A replay will be available on the Brown-Forman website for at least 30 days following the event.

Audacity IB, a nationally recognized boutique M&A investment bank and growth-to-exit consulting firm for innovative founder-owned companies, announced today that its client, Owens Design, has been acquired by Automated Industrial Robotics Inc. (“AIR”).

ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announces the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned expert in Medical Affairs with deep experience at leading biopharmaceutical organizations, Dr. Aker brings invaluable insight as ERMA deepens its impact across the Life Sciences ecosystem.

BARK (NYSE: BARK), a leading global omnichannel dog brand with a mission to make all dogs happy, announced today the return of its highly anticipated dog toy collaboration with Dunkin’, the largest coffee and donuts brand in the United States, and the Dunkin’ Joy in Childhood Foundation. Together, BARK and Dunkin’ have raised over $12.5 million for the charitable foundation since launching their partnership in 2020. Now in its sixth year, the BARK x Dunkin’ Joy partnership has become an annual tradition in high demand from dogs and dog parents.

Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 Baird Global Healthcare Conference on Tuesday, September 9, 2025, at 9:05 a.m. ET.

Kantata, a leading global provider of Professional Service Automation (PSA), today announced the appointment of Jesse Weber as Vice President of Partner Alliances. Bringing more than 14 years of experience building technology partner ecosystems at companies including Sage and SAP, Weber will lead Kantata’s strategic alliances program focusing on expanding its partner network to include Private Equity and Consulting firms.

UBS today announced that six advisors in the firm’s Southeast Wealth Management Region have been named to the 2025 Forbes America’s Top Next-Gen Wealth Advisors list.

TekStream, a cybersecurity and IT solutions leader, is bringing its Workforce Academy program to Splunk’s .conf25, which will take place in Boston from September 8 to 11. The company is also a sponsor of the event.

InvoiceCloud, a leading provider of online billing and payment solutions, today announced that the El Dorado County’s Treasurer-Tax Collector department has chosen its platform to enhance the way residents pay property taxes and other county fees. This collaboration represents a significant step forward in the California County’s commitment to delivering a more modern, efficient, and user-friendly property tax billing and payment experience.

Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna’s AI-enabled chronic kidney disease (CKD) platform and bring industry-leading point of care testing systems to emerging markets. The agreement aims to improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens Healthineers global diagnostics infrastructure. It also aims to simplify CKD workflow processes, creating better pathways for referrals and providing timely nephrology care to improve patient outcomes while reducing healthcare costs for both patients and healthcare systems.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell therapies for serious neurological and ophthalmic conditions, today announced that it has entered into a research collaboration with and through an investment from William Demant Invest A/S (WDI). WDI is an evergreen investor and the holding company for William Demant Foundation’s investment activities – a majority shareholder of the world-leading hearing healthcare company, Demant A/S.

Katalyst Data Management, a global leader in subsurface data management and data operations services, is pleased to announce that Petrobras, Brazil’s largest energy company, has officially joined its client portfolio. The contract between the two companies was signed on May 23, 2025, marking a significant milestone in Katalyst’s growth and presence in the Brazilian market.

ONTF (NYSE: ONTF) - According to a 2024 ON24 report, marketers using AI are 7X more likely to exceed business goals. Flexential, a leading provider of secure and flexible data center solutions, leveraged ON24, a leading intelligent engagement platform for B2B sales and marketing, to drive success with AI-powered digital engagement. With its digital engagement strategy on the ON24 platform, Flexential tripled its audience reach, accelerated campaign creation by 4X and significantly accelerated its marketing efficiency.

DENVER, Aug. 26, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal fourth quarter and full year financial results on Tuesday, September 9, 2025, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T.

Company to present topline 40-week Phase 2 study efficacy and safety results of migaldendranib (MGB), a novel first-in-class nanomedicine for DME and nAMD

CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- 21Shares US LLC today announced the renaming of the 21Shares Ethereum Core ETF (CETH) or “the Fund” to the 21Shares Ethereum ETF (TETH), effective August 28, 2025. The changes do not affect investment objectives, principal investment strategies or any other aspect of operations. Client holdings remain unaffected by the change.

CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will attend and present at the following investor conferences:

Verasonics, the leader in advanced ultrasound research and development, is pleased to announce a new collaboration with ImFusion GmbH, a globally recognized provider of advanced medical image computing software.

SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 9, 2025, at 4:05 p.m. ET.

    

CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in the following upcoming conferences: